Free Trial

Nu Skin Enterprises (NYSE:NUS) Rating Lowered to Hold at StockNews.com

Nu Skin Enterprises logo with Consumer Staples background

Nu Skin Enterprises (NYSE:NUS - Get Free Report) was downgraded by StockNews.com from a "buy" rating to a "hold" rating in a report released on Wednesday.

Several other brokerages also recently issued reports on NUS. Citigroup reduced their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating on the stock in a research note on Tuesday. DA Davidson decreased their target price on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a "neutral" rating on the stock in a research report on Monday, August 12th.

Get Our Latest Research Report on Nu Skin Enterprises

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS traded up $0.22 during midday trading on Wednesday, hitting $6.31. 749,182 shares of the stock were exchanged, compared to its average volume of 850,647. Nu Skin Enterprises has a twelve month low of $5.95 and a twelve month high of $20.75. The company has a current ratio of 2.12, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The company has a 50 day moving average price of $7.63 and a 200-day moving average price of $10.39. The stock has a market cap of $313.40 million, a P/E ratio of -105.17 and a beta of 1.12.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The business had revenue of $439.10 million for the quarter, compared to analyst estimates of $431.87 million. During the same period in the prior year, the business earned $0.54 earnings per share. The company's quarterly revenue was down 12.2% on a year-over-year basis. On average, research analysts forecast that Nu Skin Enterprises will post 0.78 earnings per share for the current year.

Hedge Funds Weigh In On Nu Skin Enterprises

Hedge funds and other institutional investors have recently modified their holdings of the company. Signaturefd LLC lifted its position in Nu Skin Enterprises by 72.6% during the second quarter. Signaturefd LLC now owns 3,797 shares of the company's stock valued at $40,000 after buying an additional 1,597 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in Nu Skin Enterprises by 30.5% in the 1st quarter. Public Employees Retirement System of Ohio now owns 3,926 shares of the company's stock valued at $54,000 after purchasing an additional 918 shares during the last quarter. Covestor Ltd increased its stake in shares of Nu Skin Enterprises by 90.1% in the first quarter. Covestor Ltd now owns 4,353 shares of the company's stock valued at $60,000 after purchasing an additional 2,063 shares during the period. Canada Pension Plan Investment Board acquired a new position in Nu Skin Enterprises during the 2nd quarter worth $47,000. Finally, Lazard Asset Management LLC increased its stake in shares of Nu Skin Enterprises by 92.7% during the first quarter. Lazard Asset Management LLC now owns 4,587 shares of the company's stock valued at $63,000 after acquiring an additional 2,206 shares during the period. 82.84% of the stock is owned by institutional investors and hedge funds.

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Nu Skin Enterprises right now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines